Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Molecular Neuroscience is Scopus-indexed (Q1, CiteScore 9.3), WoS SCIE, DOAJ. Published by Frontiers Media SA.
Checked against the index lists dated .
ISSN 1662-5099Verify ISSN ↗
Publisher: Frontiers Media SA
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Molecular Biology | 78 / 414 | 81st | Q1 |
| Cellular and Molecular Neuroscience | 21 / 102 | 79th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 9.3.
Frontiers in Molecular Neuroscience is Q1 in Molecular Biology (rank 78 of 414) and Q1 in Cellular and Molecular Neuroscience (rank 21 of 102), by CiteScore 2025.
Frontiers in Molecular Neuroscience is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.3, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.412, quartile Q2, with an H-index of 119.
The publisher lists an article processing charge of about US$3,801 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Molecular Neuroscience is published by Frontiers Media SA. Its ISSN is 1662-5099.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Molecular Neuroscience has an h-index of 145 and a 2-year mean of 4.98 citations per paper (OpenAlex). Its Scopus CiteScore is 9.3, quartile Q1. On 2-year citations it ranks #85 of 411 Scopus journals in Molecular Biology.
Frontiers in Molecular Neuroscience published 177 papers in 2025; its busiest recent year was 2022 with 763. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from China (41.7%), United States (20.5%) and Poland (5.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 30 retracted papers are recorded (6.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.